Our Expertise
Oncology & Precision Medicine
>60% of 2025 FDA approvals were within Oncology or Rare Biomarker driven therapies.
We understand the complexity of cancer care, from diagnosis though treatment, and evolving therapeutic innovation.
Human Understanding
We understand that as oncology becomes increasingly personalized, patients and caregivers are being asked to navigate greater complexity across diagnosis, biomarker testing, treatment choice, access, and care. The science may be becoming more precise, but the human experience is becoming more complex.
Clinical Understanding
We go beyond what people say to understand why they think, feel, decide, and behave the way they do. Combining rigorous research with behavioral and decision science, we turn deeper human understanding into actionable insight that shapes strategy and improves outcomes.
Commercial Perspective
We help brands find and understand increasingly precise patient populations, establish a differentiated role within evolving treatment paradigms, and translate complex science into clinical and human value that matters.